Detalles de la búsqueda
1.
Quality of life and disease activity of patients with rheumatoid arthritis on tofacitinib and biologic disease-modifying antirheumatic drug therapies.
Rheumatol Int
; 42(10): 1775-1783, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35759028
2.
Humanistic and economic aspects of haemophilia treatment in Bulgaria. Comparison between two therapeutic approaches: prophylactic vs. on-demand treatment.
Biotechnol Biotechnol Equip
; 28(3): 576-582, 2014 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-26019545
3.
Economic consequences of the vaccination against hepatitis A in the Bulgarian healthcare setting.
Biotechnol Biotechnol Equip
; 28(2): 366-371, 2014 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-26019522
4.
The role of insurance policies in the drug pricing landscape.
Expert Rev Pharmacoecon Outcomes Res
; 24(2): 189-202, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38064353
5.
Study of Symptom Severity and Adherence to Therapy of Myelofibrosis Patients Treated with Ruxolitinib.
Pharmaceuticals (Basel)
; 16(7)2023 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37513888
6.
Tackling reimbursement challenges to fair access to medicines - introduction to the topic.
Expert Rev Pharmacoecon Outcomes Res
; 23(6): 597-606, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37055731
7.
Therapeutic Results and Survival of Patients with Myelofibrosis Treated with Ruxolitinib-A Real-Life Longitudinal Study.
Cancers (Basel)
; 15(20)2023 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37894452
8.
How Managed Entry Agreements Influence the Patients' Affordability to Biological Medicines-Bulgarian Example.
Healthcare (Basel)
; 11(17)2023 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37685461
9.
Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making.
J Comp Eff Res
; 12(4): e220157, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36861458
10.
Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment.
Front Public Health
; 11: 1088121, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37181704
11.
Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes.
Front Pharmacol
; 14: 1244151, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37601045
12.
Recommendations for patient involvement in health technology assessment in Central and Eastern European countries.
Front Public Health
; 11: 1176200, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37465169
13.
Corrigendum to "Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications".
Biomed Res Int
; 2023: 9757348, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37065720
14.
Impact of Polypharmacy, Drug-Related Problems, and Potentially Inappropriate Medications in Geriatric Patients and Its Implications for Bulgaria-Narrative Review and Meta-Analysis.
Front Public Health
; 10: 743138, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35309221
15.
Evaluation of potentially inappropriate medication in older patients with cardiovascular diseases-STOPP/START-based study.
Front Public Health
; 10: 1023171, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36620233
16.
Analysis of Healthcare Expenditures in Bulgaria.
Healthcare (Basel)
; 10(2)2022 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35206888
17.
Using real-world evidence in healthcare from Western to Central and Eastern Europe: a review of existing barriers.
J Comp Eff Res
; 11(12): 905-913, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35726611
18.
Prevalence of potentially inappropriate prescribing in older adults in Central and Eastern Europe: a systematic review and synthesis without meta-analysis.
Sci Rep
; 12(1): 16774, 2022 10 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36202826
19.
Budget cap and pay-back model to control spending on medicines: A case study of Bulgaria.
Front Public Health
; 10: 1011928, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36438231
20.
Barriers to Use Artificial Intelligence Methodologies in Health Technology Assessment in Central and East European Countries.
Front Public Health
; 10: 921226, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35910914